Pemetrexed Actavis 500 mg Pulver till koncentrat till infusionsvätska, lösning

Kraj: Szwecja

Język: szwedzki

Źródło: Läkemedelsverket (Medical Products Agency)

Ulotka dla pacjenta Ulotka dla pacjenta (PIL)
22-05-2018

Składnik aktywny:

pemetrexeddinatrium-2,5-hydrat

Dostępny od:

Actavis Group PTC ehf.

Kod ATC:

L01BA04

INN (International Nazwa):

pemetrexeddinatrium-2,5-hydrat

Dawkowanie:

500 mg

Forma farmaceutyczna:

Pulver till koncentrat till infusionsvätska, lösning

Skład:

mannitol Hjälpämne; pemetrexeddinatrium-2,5-hydrat 604,1 mg Aktiv substans

Typ recepty:

Receptbelagt

Podsumowanie produktu:

Förpacknings: Injektionsflaska, 1 st (500 mg)

Status autoryzacji:

Avregistrerad

Data autoryzacji:

2016-08-18

Ulotka dla pacjenta

                                1
PACKAGE LEAFLET: INFORMATION FOR THE USER
PEMETREXED ACTAVIS 100 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR
INFUSION
PEMETREXED ACTAVIS 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR
INFUSION
PEMETREXED ACTAVIS 1000 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR
INFUSION
pemetrexed
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START RECEIVING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
If you get any side effects, talk to your doctor or nurse or
pharmacist. This includes any
possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Pemetrexed Actavis is and what it is used for
2.
What you need to know before you use Pemetrexed Actavis
3.
How to use Pemetrexed Actavis
4.
Possible side effects
5.
How to store Pemetrexed Actavis
6.
Contents of the pack and other information
1.
WHAT PEMETREXED ACTAVIS IS AND WHAT IT IS USED FOR
Pemetrexed Actavis is a medicine used in the treatment of cancer. It
contains the active substance
pemetrexed. Pemetrexed belongs to a group of medicines known as folic
acid analogues and disrupts
processes that are essential for cell replication.
Pemetrexed Actavis is given in combination with cisplatin, another
anti-cancer medicine, as treatment
for malignant pleural mesothelioma, a form of cancer that affects the
lining of the lung, to patients who
have not received prior chemotherapy.
Pemetrexed Actavis is also given in combination with cisplatin for the
initial treatment of patients with
advanced stage of lung cancer.
Pemetrexed Actavis can be prescribed to you if you have lung cancer at
an advanced stage if your
disease has responded to treatment or it remains largely unchanged
after initial chemotherapy.
Pemetrexed Actavis is also a treatment for patients with advanced
stage of lung cancer whose disease
has progressed after other initial chemotherapy has been used.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE PEMET
                                
                                Przeczytaj cały dokument
                                
                            

Charakterystyka produktu

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Przeczytaj cały dokument
                                
                            

Dokumenty w innych językach

Ulotka dla pacjenta Ulotka dla pacjenta angielski 25-03-2019
Charakterystyka produktu Charakterystyka produktu angielski 25-03-2019
Sprawozdanie z oceny publicznego Sprawozdanie z oceny publicznego angielski 18-08-2016